You are seeing these quotes based on previous browsing related to sectors such as
Name | Value | 1 Day Chg | 7 Day Chg | 14 Day Chg | 30 Day Chg | 90 Day Chg | Beta |
---|---|---|---|---|---|---|---|
4basebio | n/a | 1.28% | -1.56% | 3.27% | 0.89% | -1.74% | 0.2 |
4D Pharma | n/a | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | n/a |
Abcam | 134 | 0.00% | -3.24% | -2.23% | -14.03% | -9.39% | n/a |
Abzena | n/a | 0.00% | 0.00% | 0.00% | 0.00% | 93.25% | n/a |
Agronomics Limited | 475 | -0.08% | 0.42% | 0.42% | -15.42% | -32.77% | 0.2 |
Allergy Therapeutics | 268 | 2.56% | 1.59% | -1.23% | 6.67% | 12.04% | 0.3 |
Alliance Pharma | 119 | 1.80% | -3.82% | -3.51% | -0.22% | 22.10% | 1.1 |
Animalcare Group | n/a | 0.81% | 4.20% | 5.53% | 6.90% | -10.14% | -0.4 |
Anpario | n/a | -0.25% | -5.83% | 0.50% | 12.98% | 28.25% | -0.4 |
Aptamer Group | n/a | 12.99% | 17.65% | 21.21% | 58.73% | 38.89% | 0.4 |
Aqua Bounty Technologies Inc. (Reg S) | n/a | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | n/a |
Arecor Therapeutics | n/a | 0.00% | 0.66% | 2.00% | 3.38% | -15.93% | 0.1 |
Argent Biopharma Limited NPV (DI) | n/a | -2.08% | -5.05% | -5.05% | -19.66% | -15.32% | n/a |
AstraZeneca | 123 | 4.31% | 5.19% | 5.99% | -11.26% | -19.37% | 0.9 |
Avacta Group | 461 | 8.60% | 10.99% | 3.06% | -12.93% | -33.33% | 1.2 |
Benchmark Holdings | n/a | -1.69% | -5.28% | -3.45% | -13.90% | -7.16% | 0.5 |
Beximco Pharmaceuticals Ltd. GDR (Reg S) | 190 | 0.00% | 8.06% | 1.52% | 11.67% | 19.64% | n/a |
Biodexa Pharmaceuticals | 386 | 0.00% | -21.05% | -31.82% | -80.26% | -90.38% | n/a |
Biofrontera AG (DI) | n/a | 0.00% | 1.75% | 1.75% | 1.75% | -1.69% | n/a |
Bioventix | n/a | 0.63% | -2.18% | 0.90% | 3.13% | -15.15% | -0.3 |
BiVictriX Therapeutics | n/a | 0.00% | 33.33% | 17.65% | -23.08% | -16.67% | n/a |
BTG | n/a | 0.00% | 0.12% | 0.30% | 0.42% | 0.60% | n/a |
C4X Discovery Holdings | n/a | 0.00% | 40.35% | 24.03% | -9.09% | -11.44% | n/a |
Chill Brands Group | 489 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | n/a |
Cizzle Biotechnology Holdings | n/a | 3.16% | 13.08% | 3.16% | -6.67% | 22.50% | 0.7 |
Cyprotex | n/a | 0.00% | 0.63% | 0.78% | 1.26% | 8.81% | n/a |
Dechra Pharmaceuticals | 121 | 0.00% | 0.16% | 0.26% | 0.68% | 1.90% | n/a |
Deepverge Plc | 427 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | n/a |
Destiny Pharma | 410 | 0.00% | -29.41% | 9.09% | -64.71% | -82.35% | n/a |
Diurnal Group | n/a | 0.00% | 0.00% | 0.00% | 0.55% | 176.46% | n/a |
e-Therapeutics | n/a | 0.00% | -7.93% | -1.91% | -22.08% | -40.00% | n/a |
EastPharma Ltd GDR (Reg S) | n/a | 0.00% | -14.29% | -60.00% | 9.09% | 9.09% | n/a |
ECO Animal Health Group | n/a | 2.73% | -0.29% | -6.48% | 2.73% | -36.93% | -0.4 |
Eden Research | n/a | 1.71% | 13.33% | 8.68% | 3.03% | -7.75% | -0.1 |
Ergomed | n/a | 0.00% | 0.15% | 0.30% | 0.90% | 22.14% | n/a |
Faron Pharmaceuticals Oy (DI) | n/a | -0.58% | -4.62% | -7.10% | -20.19% | -17.87% | 1.7 |
Futura Medical | 479 | 1.13% | -1.32% | -12.69% | 1.36% | -3.59% | 0.9 |
Genflow Biosciences | n/a | -1.43% | -3.09% | -4.17% | -11.08% | -21.59% | 0.5 |
Genus | 128 | 3.28% | -1.28% | -8.71% | -16.56% | -1.05% | 1.5 |
Graft Polymer (UK) | n/a | 1.28% | -12.87% | 23.44% | 41.07% | 5.33% | 0.8 |
GSK | 129 | 2.21% | 2.88% | -3.08% | -7.56% | -16.19% | 0.6 |
Gunsynd | 527 | 1.67% | -0.41% | 1.67% | 1.67% | -30.29% | 0.4 |
GW Pharmaceuticals | n/a | 0.00% | -8.13% | -7.72% | -3.35% | 42.30% | n/a |
Haleon | n/a | 2.58% | 4.34% | 5.15% | 1.46% | 2.58% | 0.4 |
Hemogenyx Pharmaceuticals | 340 | -32.46% | -14.17% | -18.58% | -13.45% | -23.65% | 0.7 |
Hikma Pharmaceuticals | 125 | 4.91% | 8.15% | 7.26% | -0.46% | -2.77% | 0.5 |
Horizon Discovery Group | n/a | 0.00% | 0.00% | -1.34% | -4.90% | 86.36% | n/a |
HUTCHMED (China) Limited | 226 | -1.07% | 5.30% | 1.09% | -14.46% | 2.39% | 1.2 |
Hvivo | n/a | 0.00% | 18.92% | 37.50% | 34.69% | 1.54% | n/a |
Immupharma | 328 | -1.27% | -7.88% | -6.63% | -15.18% | 11.71% | 0.7 |
Indivior | 314 | 0.66% | 8.71% | 6.71% | 28.92% | -8.27% | 1.5 |
Inspired Capital | n/a | 0.00% | -0.58% | -0.58% | 0.00% | 12.50% | n/a |
Ixico | n/a | 9.38% | 50.39% | 52.17% | 41.89% | 38.16% | 0.2 |
LungLife AI, Inc (DI) | n/a | 5.71% | 15.63% | 8.82% | -2.63% | -28.85% | -0.4 |
Maxcyte Inc (DI/REG S) | 330 | 0.00% | 0.00% | 0.00% | 3.93% | -5.13% | n/a |
Mereo Biopharma Group | n/a | 0.00% | -10.17% | -22.06% | -18.46% | -42.39% | n/a |
Motif Bio | n/a | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | n/a |
N4 Pharma | n/a | -2.56% | 2.70% | 1.33% | 5.56% | 10.14% | n/a |
Nuformix | 322 | 0.00% | -5.00% | -5.00% | -24.00% | -72.86% | 0.1 |
Okyo Pharma Limited NPV | 403 | 0.00% | -31.71% | -30.00% | -9.68% | -74.07% | n/a |
Ondine Biomedical Inc. NPV (CDI) | n/a | 0.00% | -1.52% | -7.14% | 22.64% | 16.07% | 0.9 |
OptiBiotix Health | n/a | -1.22% | -10.37% | -3.20% | 18.05% | -49.58% | 0.6 |
Ovoca Bio (CDI) | n/a | -2.94% | -8.33% | -8.33% | 0.00% | 94.12% | 0.2 |
Oxford Biomedica | 125 | 1.82% | 2.69% | 1.82% | -1.41% | 21.21% | 1.2 |
Oxford Cannabinoid Technologies Holdings | n/a | 0.00% | -43.90% | -36.11% | -66.67% | -73.86% | n/a |
Oxford Nanopore Technologies | n/a | 4.40% | -2.06% | -4.33% | -12.07% | 6.30% | 1.3 |
Pfizer Inc. | n/a | 0.00% | 17.46% | 17.46% | 17.46% | 17.46% | n/a |
OJSC Pharmstandard GDR (Reg S) | n/a | 0.00% | -1.75% | 2.89% | -2.00% | 3.16% | n/a |
Plethora Solutions Holdings | n/a | 0.00% | -11.11% | -11.11% | 9.09% | -33.33% | n/a |
Poolbeg Pharma | n/a | 1.97% | -7.07% | -12.13% | -1.90% | -38.74% | 0.8 |
Proteome Sciences | 353 | 0.00% | 0.00% | 1.85% | -1.79% | -18.88% | 0.7 |
PureTech Health | n/a | 3.83% | -1.98% | 7.27% | 7.41% | 1.69% | 0.9 |
Quantum Pharma | n/a | 0.00% | 2.74% | 2.43% | 2.74% | 52.49% | n/a |
Redx Pharma | 278 | 0.00% | 46.34% | 36.36% | -18.92% | -25.00% | n/a |
ReNeuron Group | 394 | 0.00% | -2.96% | -2.96% | -2.96% | -2.96% | n/a |
Sareum Holdings | 594 | 1.28% | 8.22% | 7.48% | 9.72% | -11.48% | -0.2 |
Scancell Holdings | n/a | -2.59% | -14.39% | 2.73% | -2.59% | -13.87% | 0.5 |
Shield Therapeutics | n/a | -4.24% | 4.63% | 2.73% | -30.25% | -18.12% | 1.9 |
Shire Plc | n/a | 0.00% | 2.63% | 4.36% | 3.42% | 6.88% | n/a |
Silence Therapeutics | 177 | 0.00% | -1.65% | -0.93% | 5.94% | -9.17% | n/a |
Sinclair Pharma | n/a | 0.00% | 0.00% | 0.32% | 0.47% | 45.21% | n/a |
SkinBioTherapeutics | n/a | -0.06% | 15.00% | 8.48% | 19.74% | 32.21% | 1.2 |
Skyepharma | n/a | 0.00% | -1.94% | -4.47% | -6.39% | 17.35% | n/a |
Source BioScience | n/a | 0.00% | -4.11% | -1.41% | -1.41% | 2.19% | n/a |
Summit Therapeutics | n/a | 0.00% | -2.38% | -12.77% | -2.38% | -6.82% | n/a |
Synairgen | 510 | 0.00% | -3.94% | 1.31% | 0.54% | 28.61% | 1.5 |
Taihua | n/a | 0.00% | -30.00% | 59.09% | -46.15% | -72.00% | n/a |
Theracryf | 304 | -4.19% | 0.98% | -10.43% | -17.60% | -26.43% | 0.9 |
Tiziana Life Sciences | n/a | 0.00% | 11.43% | 12.50% | 7.34% | -7.87% | n/a |
Valirx | 435 | -2.24% | 22.43% | 7.38% | -6.43% | -31.77% | -0.9 |
Vectura Group | 139 | 0.00% | 0.12% | -0.12% | 0.00% | 6.74% | n/a |
Verici DX | 429 | -1.96% | 10.29% | -1.96% | -5.46% | -50.98% | 0.2 |
Vernalis plc | n/a | 0.00% | 0.49% | 0.33% | 0.82% | -4.19% | n/a |
Verona Pharma | n/a | 0.00% | 4.76% | 4.76% | -15.38% | -24.14% | n/a |
Verseon Corporation (DI/REG S) | n/a | 0.00% | 96.72% | 73.91% | -48.94% | -67.74% | n/a |
Verseon Corporation (Reg S Cat 3) | n/a | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | n/a |
Yourgene Health | n/a | 0.00% | 0.98% | 0.98% | 5.10% | 139.53% | n/a |